From Glucose to Cognition: Where Repurposed Diabetes Drugs Stand in Alzheimer Disease Marco Meglio

Published Date: 17 Nov 2026

As diabetes drugs are tested for repurposing in Alzheimer disease, the negative phase 3 EVOKE and EVOKE+ results for oral semaglutide have moved attention toward prevention and earlier, combination-based approaches.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A small rise in cancer was observed following the 1986 Chernobyl accident.

2.

CAR-T Induces Deep, Durable Remission in Smoldering Myeloma

3.

Prostate cancer, rectal exams, Casgevy approved for thalassemia, and two million cancer cases.

4.

Drug Combo's Response Rates Top 90% in Small Cell Lung Cancer Trial

5.

Perioperative Nivolumab Boosts EFS Versus Neoadjuvant-Only Nivolumab in NSCLC


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot